Fig. 5From: Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma modelsCell-based Reovirus vaccine for the treatment of established tumours. Survival of (a) B16F10 and (b) LLC-bearing mice subsequent to treatment with a single dose of cell-based vaccine. Tumour volume of same groups, (c) B16F10 and (d) LLC, showing a significant delay in tumour development in treated miceBack to article page